BRIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.172200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.746800E-01
Normal-vs-Stage2
9.967000E-01
Normal-vs-Stage3
4.634000E-01
Normal-vs-Stage4
6.413000E-01
Stage1-vs-Stage2
9.304200E-01
Stage1-vs-Stage3
3.366000E-01
Stage1-vs-Stage4
6.972400E-01
Stage2-vs-Stage3
1.497190E-01
Stage2-vs-Stage4
4.667000E-01
Stage3-vs-Stage4
2.917400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.948600E-01
Normal-vs-AfricanAmerican
8.430400E-01
Normal-vs-Asian
9.963200E-01
Caucasian-vs-AfricanAmerican
5.274000E-01
Caucasian-vs-Asian
8.156800E-01
AfricanAmerican-vs-Asian
7.610600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.630600E-01
Normal-vs-Female
9.246400E-01
Male-vs-Female
1.340820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.218400E-01
Normal-vs-Age(41-60Yrs)
9.184000E-01
Normal-vs-Age(61-80Yrs)
8.121400E-01
Normal-vs-Age(81-100Yrs)
9.975200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.343000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.202400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.515200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.751200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.558000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.483000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.389800E-01
Normal-vs-Daily Drinker
7.333400E-01
Normal-vs-Weekly Drinker
9.116400E-01
Normal-vs-Occasional Drinker
9.374800E-01
Normal-vs-Social Drinker
8.228000E-01
Non Drinker-vs-Daily Drinker
7.974000E-01
Non Drinker-vs-Weekly Drinker
8.611200E-01
Non Drinker-vs-Occasional Drinker
5.708400E-01
Non Drinker-vs-Social Drinker
3.945400E-01
Daily Drinker-vs-Weekly Drinker
6.867400E-01
Daily Drinker-vs-Occasional Drinker
4.510400E-01
Daily Drinker-vs-Social Drinker
2.702800E-01
Weekly Drinker-vs-Occasional Drinker
7.429200E-01
Weekly Drinker-vs-Social Drinker
5.452400E-01
Occasional Drinker-vs-Social Drinker
8.479600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.712000E-01
Normal-vs-Grade 2
9.465200E-01
Normal-vs-Grade 3
6.394800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.961150E-03
Grade 1-vs-Grade 3
3.89619999999757E-05
Grade 1-vs-Grade 4
7.712000E-01
Grade 2-vs-Grade 3
1.229650E-01
Grade 2-vs-Grade 4
9.465200E-01
Grade 3-vs-Grade 4
6.394800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.710600E-01
Normal-vs-NonDiabetic
9.201000E-01
Diabetic-vs-NonDiabetic
1.765230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.204400E-01
Normal-vs-NoPancreatitis
8.373800E-01
Pancreatitis-vs-NoPancreatitis
5.143200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.737600E-01
Normal-vs-N1
9.061400E-01
N0-vs-N1
6.435200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.066200E-01
Normal-vs-TP53-NonMutant
9.524400E-01
TP53-Mutant-vs-TP53-NonMutant
1.490040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
